VANCOUVER, BC, May 28, 2025
/PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY)
(OTCQX: BABYF) (FSE: 0YL) ("Else" or the
"Company"), a pioneer in wholefood, Plant-Based
nutrition for babies, toddlers, children and adults, is pleased to
announce that its CEO and Co-Founder, Hamutal Yitzhak, authored a featured op-ed
published in The Washington Times on May 25, 2025. Titled "Operation Stork Speed
will ensure babies get the nutrition they need," the
piece highlights the urgent need to modernize the infant formula
regulatory environment and emphasizes the importance of increasing
access to safe and innovative nutrition options—particularly for
infants with dietary restrictions or allergen sensitivities. The
Washington Times has a substantial
readership in Washington, D.C.,
particularly among Congress and the Administration.
"Our mission has always been to deliver a safe, plant-based
infant formula that supports healthy development and gives
families—especially those with dietary or dairy/soy allergen
concerns—greater access to trusted nutrition," said Hamutal Yitzhak, CEO and Co-Founder of Else
Nutrition. "Operation Stork Speed is an excellent initiative
designed to expand access to these types of formulas, and as noted
in the Washington Times op-ed, we look
forward to continuing to collaborate with the White House,
policymakers, and the FDA as we look to bring our unique solution
to market in a swift and responsible manner."
Regulatory Pathway and Status
Else Nutrition has developed a clean-label, whole plant-based
infant formula intended as an alternative to dairy- and soy-based
products. In 2023, the Company successfully concluded the
pre-clinical studies required and received Institutional Review
Board (IRB) approval for its infant growth clinical study
protocol—marking a key step toward U.S. Food and Drug
Administration (FDA) compliance. At present, the Company is
awaiting final authorization from the FDA to initiate its clinical
trial in the United States,
pending regulatory modernization that the company believes may be
accelerated through Operation Stork Speed. Several Congressional
Appropriators recently called on the FDA to accelerate this effort,
as directed through an oversight letter.
Policy Advocacy and Operation Stork Speed
The op-ed coincides with the recent launch of Operation Stork
Speed, an initiative by the Trump administration and Health and
Human Services Secretary Robert F. Kennedy
Jr., aimed at improving the regulatory review and safety of
infant formula in the United
States as well as encouraging innovation and
transparency in formula composition to serve unmet needs. Ms.
Yitzhak's commentary lends industry perspective to this national
conversation and urges regulatory authorities to accelerate the
path to market for scientifically supported, non-traditional
formula options.
Else Nutrition is actively engaged in this effort through direct
outreach to policymakers, bipartisan advocacy on Capitol Hill, and
consumer education. The Company continues to advocate for updated
infant formula guidelines that recognize the validity and safety of
plant-based, non-soy, allergen-friendly alternatives.
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL)
is a food and nutrition company in the international expansion
stage focused on developing innovative, clean, and Plant-Based food
and nutrition products for infants, toddlers, children, and adults.
Its revolutionary, Plant-Based, non-soy formula is a
clean-ingredient alternative to dairy-based formulas. Since
launching its Plant-Based Complete Nutrition for Toddlers, made of
whole foods, almonds, buckwheat, and tapioca, the brand has
received thousands of powerful testimonials and reviews from
parents, gained national retailer support, and achieved rapid sales
growth.
Awards and Recognition:
- "2017 Best Health and Diet Solutions" award at Milan's Global Food Innovation Summit
- #1 Best Seller on Amazon in the Fall of 2020 in the New Baby
& Toddler Formula Category
- "Best Dairy Alternative" Award 2021 at World Plant-Based
Expo
- Nexty Award Finalist at Expo West 2022 in the Plant-Based
lifestyle category
- During September 2022, Else Super
Cereal reached the #1 Best Seller in Baby Cereal across all brands
on Amazon
To delve deeper into Else Nutrition's offerings and its
revolutionary approach to nutrition, visit
www.elsenutrition.com
TSX
Neither the TSX nor its regulation services provider (as that
term is defined in the policies of the TSX) accept responsibility
for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute
"forward-looking statements" within the meaning of applicable
securities legislation. Forward-looking statements are typically
identified by words such as "will" or similar expressions.
Forward-looking statements in this press release include statements
with respect to the anticipated dates for filing the company's
financial disclosure documents. Such forward-looking statements
reflect current estimates, beliefs, and assumptions, which are
based on management's perception of current conditions and expected
future developments, as well as other factors management believes
are appropriate in the circumstances. No assurance can be given
that the foregoing will prove to be correct. Forward-looking
statements made in this press release assume, among others, the
expectation that there will be no interruptions or supply chain
failures as a result of COVID-19 and that the manufacturing,
broker, and supply logistic agreement with the company does not
terminate. Actual results may differ from the estimates, beliefs,
and assumptions expressed or implied in the forward-looking
statements. Readers are cautioned not to place undue reliance on
any forward-looking statements, which reflect management's
expectations only as of the date of this press release. The company
disclaims any obligation to update or revise any forward-looking
statements, whether as a result of new information, future events,
or otherwise, except as required by law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/else-nutrition-ceo-highlights-urgent-need-for-infant-formula-alternatives-in-the-washington-times-op-ed-302466387.html
SOURCE Else Nutrition Holdings Inc.
